CATALOGO DEI PRODOTTI DELLA RICERCA

GISONDI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.784
NA - Nord America 7.053
AS - Asia 5.051
SA - Sud America 777
AF - Africa 162
OC - Oceania 62
Continente sconosciuto - Info sul continente non disponibili 5
Totale 20.894
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.951
SG - Singapore 1.997
GB - Regno Unito 1.855
IT - Italia 1.767
CN - Cina 1.552
HK - Hong Kong 820
RU - Federazione Russa 790
BR - Brasile 699
IE - Irlanda 642
FR - Francia 604
DE - Germania 583
SE - Svezia 553
FI - Finlandia 451
KR - Corea 181
UA - Ucraina 123
NL - Olanda 101
TR - Turchia 88
ES - Italia 85
ID - Indonesia 84
TG - Togo 72
IN - India 69
AU - Australia 54
CA - Canada 53
JP - Giappone 47
AT - Austria 40
PL - Polonia 35
MX - Messico 32
BE - Belgio 28
IR - Iran 25
VN - Vietnam 22
AR - Argentina 21
BD - Bangladesh 21
CH - Svizzera 21
ZA - Sudafrica 21
UZ - Uzbekistan 17
EG - Egitto 16
CL - Cile 15
SA - Arabia Saudita 15
CZ - Repubblica Ceca 14
MY - Malesia 14
EC - Ecuador 13
MA - Marocco 13
DK - Danimarca 12
PK - Pakistan 12
PH - Filippine 10
TN - Tunisia 10
DZ - Algeria 9
GR - Grecia 9
IL - Israele 9
KE - Kenya 9
PT - Portogallo 9
RO - Romania 9
CO - Colombia 8
KZ - Kazakistan 8
NZ - Nuova Zelanda 8
TH - Thailandia 7
AL - Albania 6
BO - Bolivia 6
HR - Croazia 6
IQ - Iraq 6
JO - Giordania 6
LT - Lituania 6
MM - Myanmar 6
GE - Georgia 5
HU - Ungheria 5
IS - Islanda 5
TW - Taiwan 5
VE - Venezuela 5
BG - Bulgaria 4
BN - Brunei Darussalam 4
EE - Estonia 4
ET - Etiopia 4
GH - Ghana 4
JM - Giamaica 4
LK - Sri Lanka 4
PY - Paraguay 4
AM - Armenia 3
AZ - Azerbaigian 3
EU - Europa 3
LV - Lettonia 3
NO - Norvegia 3
UY - Uruguay 3
BH - Bahrain 2
BY - Bielorussia 2
GD - Grenada 2
HN - Honduras 2
LU - Lussemburgo 2
NP - Nepal 2
OM - Oman 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AE - Emirati Arabi Uniti 1
AO - Angola 1
BB - Barbados 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
FK - Isole Falkland (Malvinas) 1
Totale 20.876
Salva come PNG Salva come JPEG
Città #
Southend 1.591
Singapore 1.231
Chandler 1.055
Jacksonville 953
Hong Kong 804
Dublin 631
Woodbridge 552
Ashburn 474
Ann Arbor 431
Houston 429
Beijing 277
Wilmington 220
Lawrence 215
Princeton 215
Helsinki 141
Milan 136
Jinan 135
Munich 133
Verona 132
Nanjing 130
New York 129
Rome 109
Shenyang 100
The Dalles 97
Sindelfingen 93
Jakarta 74
Lomé 72
Hebei 63
Haikou 54
Santa Clara 53
Tianjin 50
Seattle 49
São Paulo 49
Changsha 48
Washington 48
Dallas 47
Moscow 47
Columbus 46
Guangzhou 44
Los Angeles 44
Nanchang 44
Redwood City 42
Madrid 40
Naples 38
Bologna 37
Hangzhou 37
Chicago 36
Zhengzhou 34
Jiaxing 32
Boardman 31
Lappeenranta 30
Amsterdam 29
Falls Church 29
Frankfurt am Main 29
Kent 29
London 29
Ningbo 28
Turin 28
Brussels 27
Redmond 27
Rio de Janeiro 27
Esslingen am Neckar 25
Vienna 25
Nuremberg 24
Venice 23
Warsaw 23
Council Bluffs 22
Fairfield 22
Taizhou 22
Belo Horizonte 21
Genoa 21
Norwalk 21
Brooklyn 20
Florence 20
Toronto 20
Parma 19
Seoul 19
Tokyo 19
Düsseldorf 18
Shanghai 18
Sydney 18
Brescia 17
Phoenix 17
Atlanta 16
Dongguan 16
Lancaster 16
San Francisco 16
Vicenza 16
Brasília 15
Curitiba 15
Fuzhou 15
Stockholm 15
Bari 14
Kuala Lumpur 14
Mexico City 14
Tashkent 14
Taiyuan 13
Campinas 12
Edinburgh 12
Enfield 12
Totale 12.583
Salva come PNG Salva come JPEG
Nome #
Pemfigoide cicatriziale di Brunsting-Perry: descrizione di un caso. 623
Interstitial granulomatous dermatitis: a distinct entity withcharacteristic histological and clinical pattern 375
La “Cross Unit”, una nuova modalità per ottimizzare il trattamento topico della psoriasi 322
Dietary supplements for lipedema 244
Il ruolo della vitamina D nella dermatite atopica 232
A systematic review of treatments for pityriasis lichenoides 224
A itchy vesiculobullous eruption in a patient with chronic lymphocytic leukemia. 134
Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails. 124
Polymorphisms, diet and nutrigenomics 122
Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy 122
State of the art and pharmacological pipeline of biologics for chronic plaque psoriasis. 118
H1 histamine receptor mediates inflammatory responses in human keratinocytes. 117
The early psoriatic arthritis screening questionnaire: a simple and fast method for the identification of arthritis in patients with psoriasis 117
Vitamin D levels in patients with psoriasis with or without arthritis 116
Squamous cell carcinoma arising in lupus vulgaris. 114
Impact of TNF-α antagonists on the quality of life in selected skin diseases 113
Tossicodermia indotta da oxcarbamazepina: descrizione di un caso. 113
Nonalcoholic fatty liver disease in patients with chronic plaque psoriasis. 109
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis 108
Steatosi epatica non alcolica in pazienti con psoriasi cronica in placche. 108
Severe impairment of quality of life in Hailey-Hailey disease. 106
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. 106
Retention rate of systemic drugs in patients with chronic plaque psoriasis 105
Advanced Glycation End Products in the Pathogenesis of Psoriasis 105
Survival rate of antitumour necrosis factor-a treatments for psoriasis in routine dermatological practice: a multicentre observational study 103
Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial 102
Balneotherapy for chronic plaque psoariasis at Comano spa in Trentino, Italy. 102
Psoriasis and the metabolic syndrome 102
Impact of the COVID-19 pandemic on melanoma diagnosis 102
Heat urticaria: a revision of published cases with an update on classification and management 102
The expectations of patients with psoriasis during an office consultation 100
Lower limbs enthesopathy in psoriasic patients without clinical signs of arthropathy: a bospital based case-control study. 99
Incidence of respiratory and allergic symptoms in Italian and immigrant children 99
Lebbra lepromatosa. 98
Psoriasi. Una guida per una migliore gestione del paziente. 98
Prevalence of symptoms experienced by patients with different clinical types of psoriasis. 97
Acneiform eruption induced by cetuximab 97
Psoriasis, the liver, and the gastrointestinal tract 97
A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis. 97
Weight reduction alone may not be sufficient to maintain disease remission in obese patients with psoriasis: a randomized, investigator-blinded study. 97
Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis 97
The efficacy and safety of topical pimecrolimus in pediatric patients with atopic dermatitis. 96
C-reactive protein and markers for thrombophilia in patients with chronic plaque psoriasis 96
Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy 96
Pimecrolimus in dermatology: atopic dermatitis and beyond. 94
Attitude to treatment of patients with psoriasis attending SPA center 94
The metabolic syndrome in psoriasis 94
Image Gallery: Pyoderma gangrenosum of the penis. 94
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 94
Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. 93
Targeting TNF-a in psoriasis and psoriatic arthritis. 93
Mild cognitive impairment in patients with moderate to severe chronic plaque psoriasis 93
Annular Lichenoid Dermatitis of Youth: Report of Six New Cases with Review of the Literature 93
Effective management of psoriasis symptom worsening durino efalizumab therapy without discontinuing treatment: A case study. 92
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis 92
The link between enthesitis and arthritis in psoriatic arthritis: a switch to a vascular phenotype at insertions may play a role in arthritis development. 91
The diagnostic and therapeutic challenge of early psoriatic arthritis 90
Erythema nodosum: etiological factors and relapses in a retrospective cohort study. 89
Dermatite atopica. 88
Complicanze dell'obesità: la cute 88
Patients with psoriasis have a higher prevalence of parental cardiovascular disease 87
Efficacy and safety of secukinumab in chronic plaque psoriasis and psoriatic arthritis therapy 87
Targeting tumor necrosis factor a in the therapy of psoriasis. 87
Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. 86
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study. 86
Hyperuricaemia in patients with chronic plaque psoriasis. 86
The importance of treating mild atopic dermatitis. 85
PSORIASIS 85
Metabolic comorbidities and psoriasis. 85
Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study 85
L’organo pelle: struttura, biologia, funzioni. 85
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008. 84
Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis 84
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review 84
Chronic plaque psoriasis is associated with increased arterial stiffness 83
Preliminary evidence that subclinical enthesopathy may predict psoriatic arthritis in patients with psoriasis 83
Aggiornamento sulla terapie biologiche della psoriasi 82
Effects of secukinumab on serum adipocytokines: preliminary data 82
New insights into the autoantibody-mediated mechanisms of autoimmune bullous diseases and urticaria. 81
Imiquimod: un ruolo nel trattamento topico della epidermodisplasia verruciforme? 81
Microcircolatory modifications of psoriatic lesions during topical therapy. 80
Perception of disease and doctor-patient relationship experienced by patients with psoriasis. A questionnaire-based study 80
Cardiometabolic comorbidities: the fingerprint of psoriasis 79
Systemic therapy of psoriasis in diabetic patients 79
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 79
Clinical and immunological profile of patients with dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid 79
Vitamin D status in patients with chronic plaque psoriasis 78
Insufficient knowledge among psoriasis patients can represent a barrier to participation in decision-making. 78
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 78
Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. 77
Usefulness of the Framingham risk score in patients with chronic psoriasis 77
Le malattie della mucosa orale 77
Serum chemerin is increased in patients with chronic plaque psoriasis and normalizes following treatment with infliximab. 77
La dermatite atopica nella seconda infanzia ed adolescenza 77
Some considerations about the importance of alliance between patients and dermatologists in psoriasis 77
Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors in Patients with Non-Small-Cell Lung Cancer 77
The need for long-term continuous therapy in moderate to severe chronic plaque psoriasis 76
Phenotypes of atopic dermatitis 76
Concept of Remission in Chronic Plaque Psoriasis 76
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products 76
Totale 10.767
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.549
article - articoli 83.689
book - libri 315
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.545
Totale 173.098
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.571 130 295 66 168 199 198 42 100 100 27 184 62
2021/20221.439 86 230 38 121 88 91 54 109 79 55 125 363
2022/20233.858 269 238 357 605 270 889 66 195 503 213 181 72
2023/20242.533 119 197 240 281 261 403 149 157 35 110 342 239
2024/20256.581 386 349 230 1.037 360 299 414 308 941 466 582 1.209
2025/2026230 230 0 0 0 0 0 0 0 0 0 0 0
Totale 21.285